• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    K-Tube Technologies

    Lyons

    Halkey-Roberts Corporation

    GS Plastic Optics

    DELMIAWORKS (IQMS)
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Carclo Technical Plastics

    Accumold

    GS Plastic Optics

    Lyons

    Eurofins Medical Device Testing
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    V-Wave Enrolls First Patients in RELIEVE-HF Pivotal Trial Assessing its Heart Failure Therapy

    Study to evaluate safety, efficacy of V-Wave's therapy in severe HF patients with preserved or reduced ejection fraction.

    V-Wave Enrolls First Patients in RELIEVE-HF Pivotal Trial Assessing its Heart Failure Therapy
    The RELIEVE HF trial will study the safety and effectiveness of the V-Wave shunt (pictured above) in patients with heart failure who remain highly symptomatic. Image courtesy of Business Wire.
    Related CONTENT
    • FDA Approves Industry’s First Off-the-Ear Audio Processor with Wireless Charging
    • Neural Response Panel to Identify Opioid Dependency Risk Wins FDA Breakthrough Designation
    • What Medtech Issues Keep You Up at Night?
    • Mobile Medical Applications: The Regulatory Framework in the U.S. and the EU
    • iSchemaView Receives FDA Clearance for RAPID CTA
    V-Wave Ltd.11.06.18
    V-Wave Ltd. has enrolled the first patients in its global, 500-patient pivotal study of its proprietary, minimally invasive implanted interatrial shunt device for treating patients with NHYA Class III and ambulatory Class IV symptomatic heart failure (HF). This randomized, controlled, double-blinded multicenter clinical trial—the RELIEVE-HF study — will evaluate the safety and effectiveness of V-Wave's device therapy in severe HF patients with either preserved or reduced ejection fraction. The study is funded by V-Wave's $70 million early 2018 C-Round financing.
     
    "Elevations in left atrial pressure (LAP) cause fluid to back-up in the lungs resulting in difficulty breathing; uncontrolled elevations in LAP are the most common cause (>90 percent) of acute hospitalizations for HF," noted Dr. Gregg W. Stone, professor of Medicine at Columbia University and director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center. "The shunt continuously regulates LAP without patient or physician intervention by diverting a small portion of blood flow from the left to the right atrium, preventing uncontrolled LAP elevations. The RELIEVE HF trial will study the safety and effectiveness of the V-Wave shunt in patients with heart failure who remain highly symptomatic despite best medical treatments."
     
    The first two patients in the RELIEVE-HF study were successfully implanted and discharged home the following morning from The Ohio State University Wexner Medical Center. Dr. Garrie Haas, director of the Heart Failure and Transplant Program is principal investigator and Drs. Scott Lilly (interventional cardiologist) and Rami Kahwash (heart failure cardiologist) are responsible for implantation and patient management, respectively.
     
    Approximately 50 major North American hospitals are expected to participate in the pivotal study with up to another 25 centers in the European Union and Israel. Further information on the study is available at https://clinicaltrials.gov/ct2/show/NCT03499236.
     
    V-Wave CEO Dr. Neal Eigler described that "The interatrial shunt provides a novel therapeutic approach for patients with chronic HF. The shunt is implanted through a catheter inserted in a vein in the leg. Prior clinical experience demonstrated device and implantation procedure safety, and statistically significant improvements in symptoms, quality of life measurements, and exercise capacity were observed compared to a matched population receiving optimal care. We are fortunate to have our study designed by the world's leading HF clinical trialists: Drs. William Abraham from the Ohio State University, Gregg Stone, from Columbia University, JoAnn Lindenfeld of Vanderbilt University, Stefan D. Anker from Charité Berlin, Germany, and Josep Rodés-Cabau, M.D., Laval University, Quebec. These physicians have planned and executed some of the most influential and successful HF and structural heart disease device trials."
     
    The study protocol allows inclusion of a broad pool of patients who are expected to have the best chance of benefitting from the treatment. The primary effectiveness outcome measure includes a hierarchical composite of mortality, heart transplant or ventricular assist device implantation, HF hospitalizations, and change in six-minute walk test distance.
     
    With more than 26 million people suffering from chronic heart failure globally (including 6 million people in the United States), heart failure is the leading cause of hospitalizations in many countries; in the United States, it is Medicare's largest expense for acute hospitalization. Heart failure patients experience repeated hospitalizations, a poor quality of life, and a greatly reduced life expectancy.
     
    
V-Wave is a privately held medical device company with offices in Israel and the United States. The V-Wave Interatrial Shunt System is under clinical investigation and is not available for sale in the United States or other countries.
    Related Searches
    • medical device company
    • medicare
    • company
    • clinical trial
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Lipid-Rich Plaque Study Results Show Ability to Identify Patients at Risk for Coronary Events Lipid-Rich Plaque Study Results Show Ability to Identify Patients at Risk for Coronary Events
    Baxter Receives CE Mark for PrisMax System and TherMax Blood Warmer Baxter Receives CE Mark for PrisMax System and TherMax Blood Warmer
    TriSalus Life Sciences Names Chief Business Officer TriSalus Life Sciences Names Chief Business Officer
    MPO Summit 2018 Conference Program Notebook MPO Summit 2018 Conference Program Notebook
    FDA OKs iHEARtest, the First Cleared Home Hearing Assessment Kit FDA OKs iHEARtest, the First Cleared Home Hearing Assessment Kit
    Former Deutsche Bank Securities Executive Joins Masimo Former Deutsche Bank Securities Executive Joins Masimo's Board of Directors
    FDA Clears Masimo FDA Clears Masimo's rainbow Acoustic Monitoring Sensor for Infant and Neonatal Patients
    Five Strategies to Gain New Business During Global Trade Tensions Five Strategies to Gain New Business During Global Trade Tensions
    TransMed7 Appoints Strategic Advisor to its Board of Directors TransMed7 Appoints Strategic Advisor to its Board of Directors
    Lumendi Receives CE Mark for DiLumen EIP Lumendi Receives CE Mark for DiLumen EIP
    Gore Gore's Molding & Occlusion Balloon for Endovascular Aortic Repair Earns FDA, Japanese, and EU Nods
    CHLA/USC Researchers Design Novel Micropacemaker CHLA/USC Researchers Design Novel Micropacemaker
    ViewRay Appoints New President & CEO; Welcomes New COO ViewRay Appoints New President & CEO; Welcomes New COO
    Electronics Integration into Disposable and Single-Use Medical Devices Electronics Integration into Disposable and Single-Use Medical Devices
    FDA OKs Embolx FDA OKs Embolx's Balloon Occlusion Microcatheter for Pressure-Directed Arterial Embolization Therapy

    Related Breaking News

    • Cardiovascular
      First U.S. Patients Treated With a Minimally Invasive, Forward Flow Heart Pump

      First U.S. Patients Treated With a Minimally Invasive, Forward Flow Heart Pump

      Impella 5.5 with SmartAssist delivers peak flows of greater than six liters per minute.
      Businesswire 12.12.19

    • Cardiovascular | Neurological
      Imperative Care Closes a Series C Financing of $85 Million for Stroke Treatments

      Imperative Care Closes a Series C Financing of $85 Million for Stroke Treatments

      The funds will support the commercial launch of the company’s portfolio.
      Imperative Care Inc. 12.10.19

    • Cardiovascular
      FDA Grants Supplemental-PMA Approval to Impulse Dynamics

      FDA Grants Supplemental-PMA Approval to Impulse Dynamics' Next-Generation Optimizer Smart System

      Product offers a new therapy for heart failure patients with reduced ejection fraction.
      Businesswire 12.10.19


    • Cardiovascular | Patient Monitoring
      VivaLNK Wearable Sensor and Software Development Kit Receive CE Mark

      VivaLNK Wearable Sensor and Software Development Kit Receive CE Mark

      The reusable patch weighs only 7.5 grams.
      PRNewswire 12.03.19

    • Cardiovascular | Surgical
      CryoLife

      CryoLife's Thoraco-abdominal Stent Graft Gains CE Mark

      First off-the-shelf option with pre-cannulated inner branch technology.
      PR Newswire 12.03.19

    • Cardiovascular
      Concept Medical Granted CE Certification for its Sirolimus Coated MagicTouch Group of Products

      Concept Medical Granted CE Certification for its Sirolimus Coated MagicTouch Group of Products

      Company is now focused on marketing the products in Europe.
      Businesswire 11.25.19


    • Cardiovascular
      Bristol-Myers Squibb-Pfizer Alliance, Fitbit Partner to Address Gaps in Afib Detection

      Bristol-Myers Squibb-Pfizer Alliance, Fitbit Partner to Address Gaps in Afib Detection

      Companies are joining forces to develop atrial fibrillation educational content to help identify and support those at increased risk of stroke.
      Businesswire 11.25.19

    • Cardiovascular | Digital Health
      Biofourmis Partners with Novartis

      Biofourmis Partners with Novartis

      Teams up to offer digital therapeutics for patients with heart failure.
      Biofourmis 11.19.19

    • Cardiovascular
      First Patient in Middle East Treated With CSI

      First Patient in Middle East Treated With CSI's Peripheral Orbital Atherectomy Technology

      Introduction of Orbital Atherectomy expands treatment options for patients with peripheral artery disease.
      Business Wire 11.19.19


    • Cardiovascular | Materials | Tubing & Extrusion
      CVC Manufactured from Special Urethane Material that Becomes Softer in the Body

      CVC Manufactured from Special Urethane Material that Becomes Softer in the Body

      Optimized design of central venous catheters reduces risk of complications.
      Flexan 11.18.19

    • Cardiovascular | Digital Health | Patient Monitoring | Software & IT
      Preventive Healthcare via Apps

      Preventive Healthcare via Apps

      Prevention through digital helpers from Fraunhofer and partners.
      Fraunhofer-Gesellschaft 11.18.19

    • Cardiovascular | Contract Manufacturing | Materials | Tubing & Extrusion
      Freudenberg Medical Launches Wave of Product and Process Innovations

      Freudenberg Medical Launches Wave of Product and Process Innovations

      Among new innovations is Helix iMC, a new technology to continuously measure the inner geometry of silicone tubes.
      Freudenberg Medical 11.18.19

    • Cardiovascular | Neurological | Surgical
      Neural Networks Enable Autonomous Navigation of Catheters

      Neural Networks Enable Autonomous Navigation of Catheters

      AI support for endovascular stroke therapy.
      Fraunhofer-Gesellschaft 11.18.19

    • Cardiovascular
      PQ Bypass Receives Unconditional IDE Approval From FDA to Start TORUS SFA Stent Graft Study

      PQ Bypass Receives Unconditional IDE Approval From FDA to Start TORUS SFA Stent Graft Study

      TORUS-2 marks second Investigational Device Exemption approved for company in less than two years.
      Business Wire 11.15.19

    • Cardiovascular | Patient Monitoring | Software & IT
      FDA OKs Ultromics

      FDA OKs Ultromics' AI-Powered Decision Support System

      AI automates cardiac analysis helping earlier detection of cardiovascular disease, enabling clinicians to improve patient care and outcomes.
      PR Newswire 11.14.19


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.